To investigate whether head-worn displays (HWDs) help mobile participants make better alarm management decisions and achieve better situation awareness than alarms alone. Background: Patient alarms occur frequently in hospitals but often do not require clinical intervention. Clinicians may become desensitized to alarms and fail to respond to clinically relevant alarms. HWDs could make patient information continuously accessible, support situation awareness, and help clinicians prioritize alarms. Method: Experiment 1 (n = 76) tested whether nonclinicians monitoring simulated patients benefited from vital sign information continuously displayed on an HWD while they performed a secondary calculation task. Experiment 2 (n = 13) tested, across three separate experimental sessions, how effectively nursing trainees monitored simulated patients' vital signs under three different display conditions while they assessed a simulated patient. Results: In Experiment 1, participants who had access to continuous patient information on an HWD responded to clinically important alarms 25.9% faster and were 6.7 times less likely to miss alarms compared to participants who only heard alarms. In Experiment 2, participants using an HWD answered situation awareness questions 18.9% more accurately overall than when they used alarms only. However, the effect was significant in only two of the three experimental sessions. Conclusion: HWDs may help users maintain continuous awareness of multiple remote processes without affecting their performance on ongoing tasks. Application: The outcomes may apply to contexts where access to continuous streams of information from remote locations is useful, such as patient monitoring or clinical supervision.

The findings are useful for designers creating visual stimuli intended to capture attention when viewed on a peripherally positioned monocular head-worn display.

Head-worn displays have the potential to assist professionals in a wide variety of contexts by providing heads-up and hands-off information in real-time. For instance, nurses may be able to use head-worn displays to maintain peripheral awareness of the well-being of multiple patients while away from the nurses’ station and the patients’ beds. However, little is known about the advantages and disadvantages of head-worn displays in such contexts. In fact, many studies have shown that head-worn displays can lead to detriments in attention and visual performance. In three experiments, we tested people’s ability to detect simple, abrupt onset stimuli in peripheral vision when using a traditional computer monitor or Google Glass™. When using Google Glass, participants were significantly less likely to detect peripheral events. These data indicate that monocular optical see-through head-worn displays can make it harder to see peripheral stimuli. Stimuli need to be developed for head-worn displays that preserve their benefits for mobile users, while overcoming some of their disadvantages.

No abstract

BackgroundEvidence for long-term effectiveness of commercial cannabis products used to treat medical symptoms is inconsistent, despite increasingly widespread use.ObjectiveTo prospectively evaluate the effects of using cannabis on self-reported symptoms of pain, insomnia, anxiety, depression, and cannabis use disorder (CUD) after 12 months of use.MethodsThis observational cohort study describes outcomes over 9 months following a 12-week randomized, waitlist-controlled trial (RCT: NCT03224468) in which adults (N = 163) who wished to use cannabis to alleviate insomnia, pain, depression, or anxiety symptoms were randomly assigned to obtain a medical marijuana card immediately (immediate card acquisition group) or to delay obtaining a card for 12 weeks delay (delayed card acquisition group). During the 9-month post-randomization period, all participants could use cannabis as they wished and choose their cannabis products, doses, and frequency of use. Insomnia, pain, depression, anxiety, and CUD symptoms were assessed over the 9-month post-randomization period.ResultsAfter 12 months of using cannabis for medical symptoms, 11.7% of all participants (n = 19), and 17.1% of those using cannabis daily or near-daily (n = 6) developed CUD. Frequency of cannabis use was positively correlated with pain severity and number of CUD symptoms, but not significantly associated with severity of self-reported insomnia, depression, or anxiety symptoms. Depression scores improved throughout the 9 months in all participants, regardless of cannabis use frequency.ConclusionsFrequency of cannabis use was not associated with improved pain, anxiety, or depression symptoms but was associated with new-onset cannabis use disorder in a significant minority of participants. Daily or near-daily cannabis use appears to have little benefit for these symptoms after 12 months of use.